← All indications
Meningitis, Bacterial
Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.
Subtype terms (6)
More specific conditions that are subtypes of Meningitis, Bacterial in the MeSH hierarchy.
- Meningitis, Escherichia coli
- Meningitis, Haemophilus
2 drugs approved
- Meningitis, Listeria
- Meningitis, Meningococcal
42 drugs (31 approved, 11 experimental)
- Meningitis, Pneumococcal
2 drugs approved
- Tuberculosis, Meningeal
20 drugs approved
Drugs by status
Approved for this indication (8)
Phase 4 trials (2)
Phase 3 trials (7)
- glycerin
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- quadrivalent groups a, c, y, and w-135 meningococcal vaccine
- Inactivated polio virus - Enhanced
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 1 Indications (2)